Postpartum depression

New England Journal of Medicine

Volumn 375, Issue 22, 2016, Pages 2177-2186

  Stewart, Donna E ^a,b,d   Vigod, Simone ^c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; COGNITIVE BEHAVIORAL THERAPY; COUNSELING; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; EXERCISE; FATIGUE; FEMALE; HORMONAL THERAPY; HUMAN; INFANT; INSOMNIA; IRRITABILITY; LEARNING DISORDER; MALE; NUTRITIONAL SUPPORT; PEER GROUP; POOR CONCENTRATION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PUERPERAL DEPRESSION; PUERPERIUM; RISK FACTOR; RISK REDUCTION; SLEEP; SOCIAL SUPPORT; TREATMENT RESPONSE; DEPRESSION; DEPRESSION, POSTPARTUM; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; PSYCHOTHERAPY; QUESTIONNAIRE;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSION; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; PSYCHOTHERAPY; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84998849878     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1607649     Document Type: Article

References (51)

1. Howard LM, Molyneaux E, Dennis C-L, Rochat T, Stein A, Milgrom J. Nonpsychotic mental disorders in the perinatal period. Lancet 2014;384:1775-88.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed.: DSM-5. Arlington, VA: American Psychiatric Publishing, 2013.
3. Wisner KL, Moses-Kolko EL, Sit DKY. Postpartum depression: a disorder in search of a definition. Arch Womens Ment Health 2010;13:37-40.
4. Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ) 2005:1-8.
5. Munk-Olsen T, Laursen TM, Pedersen CB, Mors O, Mortensen PB. New parents and mental disorders: a population-based register study. JAMA 2006;296:2582-9.
6. Paulson JF, Bazemore SD. Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA 2010;303:1961-9.
7. Wisner KL, Sit DKY, McShea MC, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry 2013;70:490-8.
8. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157:924-30.
9. Mehta D, Newport DJ, Frishman G, et al. Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling. Psychol Med 2014;44:2309-22.
10. Couto TCE, Brancaglion MYM, Alvim-Soares A, et al. Postpartum depression: a systematic review of the genetics involved. World J Psychiatry 2015;5:103-11.
11. Guintivano J, Arad M, Gould TD, Payne JL, Kaminsky ZA. Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Mol Psychiatry 2014;19:560-7.
12. Norhayati MN, Hazlina NHN, Asrenee AR, Wan Emilin WMA. Magnitude and risk factors for postpartum symptoms: a literature review. J Affect Disord 2015;175:34-52.
13. Goodman JH. Postpartum depression beyond the early postpartum period. J Obstet Gynecol Neonatal Nurs 2004;33:410-20.
14. Stein A, Pearson RM, Goodman SH, et al. Effects of perinatal mental disorders on the fetus and child. Lancet 2014;384:1800-19.
15. Esscher A, Essén B, Innala E, et al. Suicides during pregnancy and 1 year postpartum in Sweden, 1980-2007. Br J Psychiatry 2016;208:462-9.
16. Lindahl V, Pearson JL, Colpe L. Prevalence of suicidality during pregnancy and the postpartum. Arch Womens Ment Health 2005;8:77-87.
17. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987;150:782-6.
18. Committee on Obstetric Practice. The American College of Obstetricians and Gynecologists committee opinion no. 630: screening for perinatal depression. Obstet Gynecol 2015;125:1268-71.
19. Earls MF, Committee on Psychosocial Aspects of Child and Family Health American Academy of Pediatrics. Incorporating recognition and management of perinatal and postpartum depression into pediatric practice. Pediatrics 2010;126:1032-9.
20. Myers E, Aubuchon-Endsley N, Bastian L, et al. Efficacy and safety of screening for postpartum depression: AHRQ publication no. 13-EHC064-EF. Rockville, MD: Agency for Healthcare Research and Quality, 2013.
21. Antenatal and postnatal mental health: clinical management and service guidance. London: National Institute for Health and Care Excellence, 2014 (http://www.nice.org.uk/guidance/cg192).
22. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
23. Bosanquet K, Bailey D, Gilbody S, et al. Diagnostic accuracy of the Whooley questions for the identification of depression: a diagnostic meta-analysis. BMJ Open 2015;5(12):e008913.
24. Wisner KL, Parry BL, Piontek CM. Postpartum depression. N Engl J Med 2002;347:194-9.
25. Milgrom J, Gemmill AW, Bilszta JL, et al. Antenatal risk factors for postnatal depression: a large prospective study. J Affect Disord 2008;108:147-57.
26. Yazici E, Kirkan TS, Aslan PA, Aydin N, Yazici AB. Untreated depression in the first trimester of pregnancy leads to postpartum depression: high rates from a natural follow-up study. Neuropsychiatr Dis Treat 2015;11:405-11.
27. Dennis CL, Dowswell T. Psychosocial and psychological interventions for preventing postpartum depression. Cochrane Database Syst Rev 2013;2:CD001134.
28. Dennis C-L, Chung-Lee L. Postpartum depression help-seeking barriers and maternal treatment preferences: a qualitative systematic review. Birth 2006;33:323-31.
29. Byatt N, Levin LL, Ziedonis D, Moore Simas TA, Allison J. Enhancing participation in depression care in outpatient perinatal care settings: a systematic review. Obstet Gynecol 2015;126:1048-58.
30. Dennis CL, Hodnett E. Psychosocial and psychological interventions for treating postpartum depression. Cochrane Database Syst Rev 2007;4:CD006116.
31. Ashford MT, Olander EK, Ayers S. Computer- or Web-based interventions for perinatal mental health: a systematic review. J Affect Disord 2016;197:134-46.
32. Molyneaux E, Howard LM, McGeown HR, Karia AM, Trevillion K. Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev 2014;9:CD002018.
33. Lam RW, Parikh SV, Ramasubbu R, et al. Effects of combined pharmacotherapy and psychotherapy for improving work functioning in major depressive disorder. Br J Psychiatry 2013;203:358-65.
34. Orsolini L, Bellantuono C. Serotonin reuptake inhibitors and breastfeeding: a systematic review. Hum Psychopharmacol 2015;30:4-20.
35. Gentile S. Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index. Drug Saf 2007;30:107-21.
36. Hempel G. Drug monitoring and clinical chemistry. Vol. 5. Philadelphia: Elsevier, 2004.
37. Food and Drug Administration. Review of three pharmacokinetic studies in adolescent children 12-17 years for Lexapro. May 22, 2008 (http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM226545.pdf).
38. Sigurdsson HP, Hefner G, Ben-Omar N, et al. Steady-state serum concentrations of venlafaxine in patients with latelife depression: impact of age, sex and BMI. J Neural Transm (Vienna) 2015;122:721-9.
39. Waldschmitt C, Vogel F, Pfuhlmann B, Hiemke C. Duloxetine serum concentrations and clinical effects: data from a therapeutic drug monitoring (TDM) survey. Pharmacopsychiatry 2009;42:189-93.
40. Smit M, Dolman KM, Honig A. Mirtazapine in pregnancy and lactation - a systematic review. Eur Neuropsychopharmacol 2016;26:126-35.
41. Jaquenoud Sirot E, Harenberg S, Vandel P, et al. Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression. J Clin Psychopharmacol 2012;32:622-9.
42. Sriraman NK, Melvin K, Meltzer-Brody S. ABM clinical protocol #18: use of antidepressants in breastfeeding mothers. Breastfeed Med 2015;10:290-9.
43. Gentile S. Tricyclic antidepressants in pregnancy and puerperium. Expert Opin Drug Saf 2014;13:207-25.
44. Lam RW, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: introduction and methods. Can J Psychiatry 2016;61:506-9.
45. Dennis CL, Ross LE, Herxheimer A. Oestrogens and progestins for preventing and treating postpartum depression. Cochrane Database Syst Rev 2008;4:CD001690.
46. Myczkowski ML, Dias AM, Luvisotto T, et al. Effects of repetitive transcranial magnetic stimulation on clinical, social, and cognitive performance in postpartum depression. Neuropsychiatr Dis Treat 2012;8:491-500.
47. Deligiannidis KM, Freeman MP. Complementary and alternative medicine therapies for perinatal depression. Best Pract Res Clin Obstet Gynaecol 2014;28:85-95.
48. Postpartum Depression: Action Towards Causes and Treatment (PACT) Consortium. Heterogeneity of postpartum depression: a latent class analysis. Lancet Psychiatry 2015;2:59-67.
49. Clinical practice guidelines: depression and related disorders - anxiety, bipolar disorder and puerperal psychosis - in the perinatal period: a guideline for primary care health professionals. Melbourne, VIC, Australia: Beyond Blue, February 2011 (http://resources.beyondblue.org.au/prism/file?token=BL/0891).
50. Scottish Intercollegiate Guidelines Network (SIGN). SIGN 127: management of perinatal mood disorders: a national clinical guideline. Edinburgh: Healthcare of perinatal mood disorders: a national Improvement Scotland, March 2012 (http://www.sign.ac.uk/pdf/sign127.pdf).
51. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. 2010 (http://psychiatryonline.org/pb/assets/raw/sitewide/practice-guidelines/guidelines/mdd.pdf).